{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:25Z","timestamp":1753891225222,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Limited information exists on any interactions between hydroxyurea (HU) and antimalarials in sickle cell disease (SCD). We evaluated changes in clinical and laboratory parameters among children with SCD on HU therapy treated with artemether-lumefantrine (AL) for acute uncomplicated malaria (UM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective, non-randomized, pilot study of 127 children with SCD (23, UM; 104, steady state) were recruited from three hospitals in Accra. UM participants were treated with standard doses of AL and followed up, on days 1, 2, 3, 7, 14, and 28. Venous blood was collected at baseline and follow-up days in participants with UM for determination of malaria parasitaemia, full blood count, reticulocytes, and clinical chemistry. Further, <jats:italic>Plasmodium falciparum<\/jats:italic> identification of rapid diagnostic test (RDT) positive samples was done using nested polymerase chain reaction (PCR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among SCD participants with UM, admission temperature, neutrophils, alanine-aminotransferase, gamma-glutamyl-transferase, and haemoglobin significantly differed between HU recipients (HU+) and steady state, while white blood cell, neutrophils, reticulocytes, bilirubin, urea, and temperature differed significantly between non-HU recipients (no-HU), and steady state. Mean parasitaemia (HU+, 2930.3 vs. no-HU, 1,060, <jats:italic>p<\/jats:italic> =\u20090.74) and adverse events (HU+, 13.9% vs. no-HU, 14.3%), were comparable (<jats:italic>p<\/jats:italic> =\u20090.94). Day 28 reticulocyte count was higher in the HU+ (0.24) (0.17 to 0.37) vs. no-HU, [0.15 (0.09 to 0.27), <jats:italic>p<\/jats:italic> =\u20090.022]. Significant differences in lymphocyte [HU+ 2.74 95% CI (\u22125.38 to 58.57) vs. no-HU \u22120.34 (\u22123.19 to 4.44), <jats:italic>p<\/jats:italic> =\u20090.024]; bilirubin [HU+, \u22124.44 (\u221216.36 to 20.74) vs. no-HU \u221218.37 (\u2212108.79 to \u22127.16)]; and alanine aminotransferase, [HU+, \u22124.00 (\u221248.55 to 6.00) vs. no-HU, 7.00 (\u221222.00 to 22.00)] were observed during follow up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Parasite clearance and adverse event occurrence were comparable between SCD children treated with AL irrespective of HU status. However, distinct patterns of changes in laboratory indices suggest the need for larger, more focused studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1291330","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T10:55:04Z","timestamp":1700736904000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and laboratory characteristics of children with sickle cell disease on hydroxyurea treated with artemether-lumefantrine for acute uncomplicated malaria"],"prefix":"10.3389","volume":"10","author":[{"given":"Catherine","family":"Segbefia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth Kwabena","family":"Amponsah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adwoa K. A.","family":"Afrane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mame Yaa","family":"Nyarko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Brew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihad","family":"Salifu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Yao","family":"Ahorhorlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Malik","family":"Sulley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Fokuo","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Obeng","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/tmi.12056","article-title":"Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease","volume":"18","author":"Aneni","year":"2013","journal-title":"Trop Med Int Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"E380","DOI":"10.1002\/ajh.26676","article-title":"High incidence of malaria in patients with sickle cell disease","volume":"97","author":"Mkombachepa","year":"2022","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-2257.2000.00292.x","article-title":"Acute sickle cell syndromes in Nigerian adults","volume":"22","author":"Ibidapo","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e2012065","DOI":"10.4084\/MJHID.2012.065","article-title":"Sickle cell anaemia and malaria","volume":"4","author":"Luzzatto","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12879-019-4757-x","article-title":"Malaria in patients with sickle cell anaemia: burden, risk factors and outcome at the Laquintinie hospital, Cameroon","volume":"20","author":"Eleonore","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12288-013-0261-4","article-title":"Hydroxyurea in sickle cell disease: drug review","volume":"30","author":"Agrawal","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood.2022017051","article-title":"Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa","volume":"141","author":"Olupot-Olupot","year":"2023","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1182\/blood-2017-06-788935","article-title":"Novel use of hydroxyurea in an African region with malaria (NOHARM): a trial for children with sickle cell anemia","volume":"130","author":"Opoka","year":"2017","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1475-2875-13-369","article-title":"A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria","volume":"13","author":"Adjei","year":"2014","journal-title":"Malar J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1542\/peds.2007-2022UUU","article-title":"Screening newborns for sickle cell disease in Ghana: table 1","volume":"121","author":"Ohene-Frempong","year":"2008","journal-title":"Pediatrics"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0006-2952(00)00271-9","article-title":"Inactivation of artemisinin by thalassemic erythrocytes","volume":"59","author":"Charoenteeraboon","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood-2014-02-555953","article-title":"Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins","volume":"124","author":"Jaur\u00e9guiberry","year":"2014","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1086\/657402","article-title":"Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute plasmodium falciparum malaria","volume":"51","author":"Bethell","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12936-017-1698-y","article-title":"Artemether-lumefantrine and liver enzyme abnormalities in non-severe plasmodium falciparum malaria in returned travellers: a retrospective comparative study with quinine-doxycycline in a Portuguese centre","volume":"16","author":"Silva-Pinto","year":"2017","journal-title":"Malar J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jceh.2021.07.015","article-title":"Herbal immune booster-induced liver injury in the COVID-19 pandemic","volume":"12","author":"Rastogi","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e20649","DOI":"10.7759\/cureus.20649","article-title":"Response to hydroxyurea in a patient with sickle cell hepatopathy: a case report","volume":"13","author":"Safhi","year":"2021","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajh.22259","article-title":"More definitions in sickle cell disease: steady state v base line data","volume":"87","author":"Ballas","year":"2012","journal-title":"Am J Hematol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1186\/s12879-020-05625-z","article-title":"Association between haematological parameters and sickle cell genotypes in children with plasmodium falciparum malaria resident in Kisumu County in Western Kenya","volume":"20","author":"Kosiyo","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1640480","article-title":"Comediation of erythrocyte haemolysis by erythrocyte-derived microparticles and complement during malaria infection","volume":"2020","author":"Kyeremeh","year":"2020","journal-title":"Adv Hematol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1532\/LH96.07008","article-title":"Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia","volume":"13","author":"Bagdasaryan","year":"2007","journal-title":"Lab Hematol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","article-title":"How I use hydroxyurea to treat young patients with sickle cell anemia","volume":"115","author":"Ware","year":"2010","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1182\/blood-2018-08-865618","article-title":"Platelets in malaria pathogenesis","volume":"132","author":"O\u2019Sullivan","year":"2018","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/infdis\/jiu487","article-title":"Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia","volume":"211","author":"Lampah","year":"2015","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/1475-2875-11-396","article-title":"Foetal haemoglobin and the dynamics of paediatric malaria","volume":"11","author":"Billig","year":"2012","journal-title":"Malar J"},{"key":"ref28","article-title":"Simultaneous adjunctive treatment of malaria and its co-evolved genetic disorder sickle cell anaemia","author":"Safeukui","year":"2022","journal-title":"Microbiology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1365-3024.2006.00907.x","article-title":"Effects of hydroxyurea on malaria, parasite growth and adhesion in experimental models","volume":"28","author":"Pino","year":"2006","journal-title":"Parasite Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"922377","DOI":"10.3389\/fimmu.2022.922377","article-title":"Neutrophils in malaria: a double-edged sword role","volume":"13","author":"Babatunde","year":"2022","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12804","article-title":"The regulation of CD4+ T cells during malaria","volume":"293","author":"Kumar","year":"2020","journal-title":"Immunol Rev"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2249.2007.03412.x","article-title":"Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation","volume":"149","author":"Benito","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1201-9712(01)90048-7","article-title":"Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa\u2019s HIV\/AIDS problem?","volume":"5","author":"Sanne","year":"2001","journal-title":"Int J Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4269\/ajtmh.17-0754","article-title":"The dynamics of liver function test abnormalities after malaria infection: a retrospective observational study","volume":"98","author":"Woodford","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e26833","DOI":"10.1002\/pbc.26833","article-title":"Hydroxyurea therapy in UK children with sickle cell anaemia: a single-centre experience","volume":"65","author":"Phillips","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4269\/ajtmh.14-0490","article-title":"Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa","volume":"92","author":"Ndeffo Mbah","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e0264339","DOI":"10.1371\/journal.pone.0264339","article-title":"Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated plasmodium falciparum malaria in sub-Saharan Africa: a systematic review and meta-analysis","volume":"17","author":"Marwa","year":"2022","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7371681","article-title":"Therapeutic efficacy of artemether-lumefantrine (Coartem\u00ae) for the treatment of uncomplicated falciparum malaria in Africa: a systematic review","volume":"2020","author":"Derbie","year":"2020","journal-title":"J Parasitol Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1051\/parasite\/2021063","article-title":"Artemisinin derivative-containing therapies and abnormal hemoglobin: do we need to adapt the treatment?","volume":"28","author":"Gbessi","year":"2021","journal-title":"Parasite"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","article-title":"The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data","volume":"15","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/cpt.1531","article-title":"Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether-lumefantrine for uncomplicated malaria","volume":"106","author":"Chotsiri","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","article-title":"Artemether-lumefantrine treatment of uncomplicated plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data","volume":"13","year":"2015","journal-title":"BMC Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12936-021-03585-6","article-title":"Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017\u20132018","volume":"20","author":"Gansan\u00e9","year":"2021","journal-title":"Malar J"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12936-021-04021-5","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda","volume":"20","author":"Ebong","year":"2021","journal-title":"Malar J"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ckj\/sfx027","article-title":"Sickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy","volume":"10","author":"Audard","year":"2017","journal-title":"Clin Kidney J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3324\/haematol.2010.028167","article-title":"Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania","volume":"96","author":"Cox","year":"2011","journal-title":"Haematologica"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/pathogens10080985","article-title":"Suspected severe malaria in a Sudanese patient affected by sickle cell disease who was treated with hydroxyurea","volume":"10","author":"Chiopris","year":"2021","journal-title":"Pathogens"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1291330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T10:55:08Z","timestamp":1700736908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1291330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":47,"alternative-id":["10.3389\/fmed.2023.1291330"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1291330","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"article-number":"1291330"}}